Bevacizumab (Avastin®), a humanized anti-vascular endothelial growth factor (VEGF) monoclonal antibody for cancer therapy is used as anti-angiogenic [115]; and paclitaxel (Taxol®), a cyclodecane first isolated from Taxus brevifolia, stabilizes microtubules in their polymerized form, leading to cell death [116]. This evidence concerns the gene VEGFA and cancer.